Is this you?
Request access for Care Access with your @careaccess.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 8Lift (cardio sample) 0.34Recruit soph 0.57
Quality Scorecard (1–100)
Overall81Recruit85Ops79Sponsor81Ther76
Performance (observed)
Historical trials
312
Completed
139
Terminated/Withdrawn
33
Completion rate
81%
Active now
135
Phase 2
63
Phase 3
196
Realized enrollment
1,533,912
First study year
2000
Years active
26
Match confidence
high
Enrollment velocity (inf)
58,997
Therapeutic
Areas
Multiple (heart health, kidney health, primary care focus)
Specialties
Cardiovascular; health screenings and general clinical research
Breadth (conditions)
273
Languages
English + Spanish (detected)
States
TX, GA (expanding); Global (Brazil acquisition)
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y; Future of Medicine program with 1000+ annual health screenings
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong; DTaRA involvement, decentralized trial content, health equity focus
Capability notes
Decentralized clinical trial model; mobile sites on demand; hub-and-spoke model; BARDA D-COHRe partnership; community health screenings; Sites On Demand innovation; healthcare system partnerships; Walmart Healthcare Research Institute partnership (2026); patient education and outreach; global capability
Relationships
Sponsors
Eli Lilly and Company; AbbVie; Gilead Sciences; Sanofi; Janssen Research & Development, LLC; Shire
CROs
IQVIA Biotech; IQVIA Pty Ltd; PRA Health Sciences; Parexel; Syneos Health; Teva Branded Pharmaceutical Products R&D LLC
Partnerships
Walmart, Association of Black Cardiologists, U.S. Dept Health & Human Services, Aotearoa Clinical Trials (NZ), CEMEC (Brazil)
Owner / parent
Private; Partnership with Walmart Healthcare Research Institute; Acquisition of CEMEC (Brazil); DTRA member
Acquisitions
CEMEC (Centro Multidisciplinar de Estudos Clínicos, Brazil) acquired
Expansion
Brazil (CEMEC acquisition); international presence (NZ, Brazil)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Unknown
Tech & DCT
eSource
Yes
Builds tech
Builds tech internally (technology-enabled DCT platform)
DCT / decentralized
Y; decentralized trials focus with mobile research capabilities
Tech stack
Technology-enabled patient recruitment; supply chain, logistics infrastructure; telemedicine/remote monitoring implied; integrated technology platform
Recruiting visible
Y
Notes
Innovation-focused DCT network with strong technology infrastructure and rapid expansion. Decentralized model, patient-centric approach, Walmart partnership, global capability. Strong Intera fit: tech-forward, DCT-focused, recruitment-driven (health screenings), expanding rapidly, multiple concurrent studies, diverse geographic reach, innovation-oriented. [Validated: 11 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 0.78Liftability 0.34Overall81
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.